NCT04080102

Brief Summary

Purpose: The primary purpose is to determine the combined effects of essential amino acids (EAA) supplementation and high intensity interval training (HIIT) on body composition, muscle characteristics, and muscle architecture in overweight men and women over the course of eight weeks. A secondary purpose is to determine the metabolic effects of EAA supplementation and HIIT on whole body protein turnover, metabolic rate, substrate metabolism, and metabolomics. A tertiary purpose is to evaluate the modulatory effects of sex on body composition, metabolism, metabolic profile, cardiorespiratory fitness, and hunger and satiety in response to EAA supplementation and HIIT. Participants: Healthy overweight and obese men and women (30-50 years) Procedures (methods): In a block randomized design, 78 healthy, overweight or obese men and women will be randomized, to one of four, eight-week intervention groups using a 2:2:2:1 group allocation design: 1) essential amino acids (EAA) supplementation (7.2 grams EAA daily); 2) HIIT, two days per week of cycle ergometry training; 3) EAA + HIIT; or 4) control (CON), receiving no intervention. Measurements of body composition, muscle characteristics, resting metabolic rate, substrate metabolism, and cardiorespiratory fitness will be measured at baseline, 4-weeks, and 8-weeks. Metabolomics and whole body protein turnover will also be measured at baseline and 8-weeks. Subjects will be asked to arrive to testing sessions following a 12 hour fast (except for water), consuming no food, caffeine, or alcohol. Participants will also be asked to abstain from physical activity for 24 hours prior to testing. Subjects will complete one electronic contact (phone/email screening) and up to 22 in-person sessions (enrollment; 5 testing sessions \[2 at base, 1 at 4week, 2 at 8week\]; 16 training sessions \[for HIIT and EAA+HIIT\]) over the course of 8 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 6, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 5, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2020

Completed
Last Updated

April 30, 2020

Status Verified

April 1, 2020

Enrollment Period

10 months

First QC Date

August 26, 2019

Last Update Submit

April 29, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Fat Free Mass (kg)

    Determined from a multi-compartment model

    8 weeks

  • Fat mass (kg)

    Determined from a multi-compartment model

    8 weeks

Secondary Outcomes (2)

  • Muscle cross sectional area (cm3)

    8 weeks

  • Echo intensity (a.u.)

    8 weeks

Other Outcomes (1)

  • Metabolic rate (kcal/day)

    8 weeks

Study Arms (4)

High intensity interval training (HIIT)

EXPERIMENTAL
Other: High Intensity Interval Training

Essential Amino Acid Supplement

EXPERIMENTAL
Dietary Supplement: Essential Amino Acid

High intensity interval training + Essential Amino Acid

EXPERIMENTAL
Other: High intensity interval training and essential amino acid supplement

Control

NO INTERVENTION

Interventions

Exercise

High intensity interval training (HIIT)
Essential Amino AcidDIETARY_SUPPLEMENT

Oral ingestion of a powdered dietary supplement

Essential Amino Acid Supplement

Exercise and dietary supplement

High intensity interval training + Essential Amino Acid

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women (25-50 years).
  • Overweight and obese: body mass index (BMI) of 27 - 40 kg·m-2 and/or percent body fat \> 25% for men, and BMI of 25 - 40 kg·m-2 and/or Percent Body Fat \> 30% for women.
  • Healthy, non-smokers.
  • Women: eumenorrheic, reporting consistent menstruation, having 3 regular cycles in the 3 months prior to enrollment, and not pregnant or planning on becoming pregnant.

You may not qualify if:

  • Have current and/or history of cardiovascular disease, diabetes, metabolic, thyroid, pulmonary, renal, hepatic, gastrointestinal, musculoskeletal disorders or medical or surgical events, such as bariatric surgery, heart surgery, or any joint or musculoskeletal surgeries occurring in the 6-months prior to enrollment, that may significantly influence study outcomes or prevent safe participation.
  • Have uncontrolled hypertension or an abnormal electrocardiogram.
  • Have a diagnosed mental disorder
  • Inconsistently taking medications or taking medications that may influence study outcomes.
  • Participating in more than 150 minutes per week of moderate exercise, more than 2 days per week of resistance training, or currently participating in high intensity interval training or participated in HIIT within the previous 12 weeks.
  • Lost or gained greater than eight pounds within three months prior to the enrollment.
  • Currently consuming a high protein diet (,1.6 g·kg-1·day-1 and \<25% of calories from protein).
  • Currently consuming meal replacements or dietary supplements that may taurine, or beta-hydroxy beta-methylbutyrate) within eight weeks prior to the enrollment date.
  • Reports any known sensitivity to the Essential Amino Acid treatment.
  • Has participated in another clinical trial within four weeks prior to enrollment that in the opinion of the PI would influence the results.
  • Has severely impaired hearing or speech or inability to speak English.
  • Unwilling or unable to comply with the study protocol, including abstaining from, caffeine, tobacco, alcohol, and physical activity before testing days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Applied Physiology Laboratory, Fetzer Hall Room 25

Chapel Hill, North Carolina, 27599, United States

Location

Related Publications (1)

  • Hirsch KR, Greenwalt CE, Cabre HE, Gould LM, Brewer GJ, Blue MNM, Ferrando AA, Huffman KM, Mayer-Davis EJ, Ryan ED, Smith-Ryan AE. Metabolic effects of high-intensity interval training and essential amino acids. Eur J Appl Physiol. 2021 Dec;121(12):3297-3311. doi: 10.1007/s00421-021-04792-4. Epub 2021 Aug 24.

MeSH Terms

Conditions

Obesity

Interventions

High-Intensity Interval TrainingAmino Acids, Essential

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaAmino AcidsAmino Acids, Peptides, and Proteins

Study Officials

  • Abbie Smith-Ryan, PhD

    University of North Carolina, Chapel Hill

    STUDY DIRECTOR
  • Katie Hirsch, MA

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2019

First Posted

September 6, 2019

Study Start

March 1, 2019

Primary Completion

January 5, 2020

Study Completion

January 5, 2020

Last Updated

April 30, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 12 to 24 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with University of North Carolina (UNC).

Time Frame
Deidentified individual data that supports the results will be shared beginning 12 to 24 months following publication.
Access Criteria
An investigator who proposes to use the data must have approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and execute a data use/sharing agreement with UNC.

Locations